Skip to main content
Billions Co.,Ltd. logo

Billions Co.,Ltd. — Investor Relations & Filings

Ticker · 044480 ISIN · KR7044480002 KO Wholesale and retail trade
Open in API
Filings indexed 590 across all filing types
Latest filing 2021-03-25 AGM Information
Country KR South Korea
Listing KO 044480

About Billions Co.,Ltd.

http://www.unidus.co.kr

Billions Co.,Ltd. is a company with diversified operations in the entertainment and manufacturing sectors. In the entertainment field, the company is involved in artist management and the production of dramas and movies. Concurrently, its manufacturing division produces and markets latex medical products, including prophylactics, surgical gloves, and finger cots. The company has previously operated under different names, including Blade Entertainment Co Ltd and Unidus Corporation, reflecting its distinct business segments.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Kyungnam Biopharma. It contains the meeting agenda, date, location, and detailed management information including financial statements (balance sheet, income statement, statement of changes in equity) to be approved at the meeting. This type of document is standard for proxy solicitation and shareholder information materials provided ahead of an AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2021-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is titled '감사보고서 제출' (Submission of Audit Report) and provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the fiscal year. It explicitly states that the audit report has been received and is being submitted to the regulatory body. According to the 'Menu vs Meal' rule, this is an announcement of the audit report's availability rather than the full, multi-page audit report document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2020
2021-03-23 Korean
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 48th fiscal year (2020), covering the period from January 1, 2020, to December 31, 2020. It includes detailed company information, history, capital changes, governance, and business operations. In the South Korean regulatory context (DART system), a 'Business Report' (사업보고서) is the equivalent of an Annual Report (10-K), as it provides comprehensive financial and operational disclosures for the full fiscal year. FY 2020
2021-03-23 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding a change in the company's market classification (소속부변경) for Gyeongnam Bio Pharma. It does not contain full financial statements or detailed reports, but rather serves as a formal notification of a regulatory status change. As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory announcement category.
2021-03-23 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Gyeongnam Bio Pharma. It outlines the date, location, and agenda items (such as approval of financial statements, election of directors, and amendments to articles of incorporation). This type of document is a standard proxy solicitation material sent to shareholders to inform them of an upcoming meeting and the matters to be voted upon, which falls under the Proxy Solicitation & Information Statement category.
2021-03-16 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by Kyungnam Bio Pharma regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for this scheduling conflict and confirms compliance with regulatory reporting requirements. Since it is a specific regulatory notification regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2021-03-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.